BioAgilytix Labs, Inc., specializes in large-molecule bioanalysis for pharmaceutical and biotech companies. Headquartered in Research Triangle Park, North Carolina, BioAgilytix is a global leader in outsourced laboratory services developing, optimizing and conducting bioanalytic testing, third-party validation, supporting pharmaceutical discovery, pre-clinical and clinical development and manufacturing.
RENU 28 has received 5-star accreditation—the highest possible—by leading European dermatological research institute, Dermatest. In a 28-day study, RENU 28 was shown to:
- Reduce eye wrinkle depth by 21%
- Improve wrinkles overall by 23%
- Improve facial skin texture by 22%
- Increase skin’s smoothness by 23
- Increase skin’s elasticity by 20%
- Increase skin’s moisture by 11%
Redox signaling technology has not been evaluated by the FDA. However, ASEA manufacturing is FDA registered, NSF certified, and meets all FDA Good Manufacturing Practices (GMP).
NSF International’s GMP Registration Program enables manufacturers to become independently registered by NSF to meet GMP requirements. The program is open to manufacturers of dietary supplements who want to demonstrate their commitment to public safety.
These GMP requirements are listed in Section 8 of NSF/ANSI 173, which is the only accredited American National Standard in the dietary supplement industry developed in accordance with the FDA’s 21 CFR part 111.
The World Anti-Doping Agency has recognized and certified ASEA as a safe product for use, and it contains no prohibited substances.